Health Care & Life Sciences » Biotechnology | Vascular Biogenics Ltd.

Vascular Biogenics Ltd. | Mutual Funds

Mutual Funds that own Vascular Biogenics Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Delaware Healthcare Fund
200,000
0.56%
0
0.05%
03/31/2018
60,659
0.17%
0
0.19%
09/06/2018
Fidelity Nasdaq Composite Index
11,422
0.03%
0
0%
07/31/2018
10,800
0.03%
0
0.27%
05/31/2018
10,129
0.03%
0
0.09%
05/31/2018
Market Vectors - Israel ETF
8,271
0.02%
0
0.03%
09/05/2018
3,914
0.01%
650
0.08%
05/31/2018
432
0%
225
0.03%
06/28/2018

About Vascular Biogenics

View Profile
Address
8 HaSatat Street
Modi'in JM 7178106
Israel
Employees -
Website http://www.vblrx.com
Updated 07/08/2019
Vascular Biogenics Ltd. is in the clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of first-in-class treatments for cancer. It offers different programs for cancer and inflammatory disease patients such as vascular targeting system and Lecinoxoids. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.